Condition: Systemic Inflammatory Response · Diabetes Mellitus, Type 2 · Cardiovascular Diseases · Sponsor: University of Alberta
The purpose of the study is to ascertain whether traditional kefir not only enhances vascular health but also contributes to improved immune outcomes in both male and female participants at higher risk or living with Type 2 Diabetes (T2D) after 12 weeks of treatment.
This description comes directly from the study's public registry record.
Paulina Aldana Hernandez, PhD · 780-492-9506 · paldana@ualberta.ca
Always discuss trial participation with your own doctor first.
| University of Alberta | Edmonton, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06695221